Bayer Schering Oncology Candidate Becomes First Syndax Pipeline Compound

Biopharma inlicenses Bayer’s selective histone deacetylase inhibitor to develop in combination therapies.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet